Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia

BACKGROUND. The risk of infection associated with specific treatments of chronic active antibody-mediated rejection (cAMR) after kidney transplantation remains unknown. METHODS. This was a single-center study of kidney transplant recipients treated with pulse steroids, intravenous immunoglobulin (IV...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transplant Direct
Päätekijät: Joachim, Emily, Parajuli, Sandesh, Swanson, Kurtis J., Aziz, Fahad, Garg, Neetika, Mohamed, Maha, Mandelbrot, Didier, Djamali, Arjang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2020
Aiheet:
Kidney Transplantation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738046/
https://ncbi.nlm.nih.gov/pubmed/33335983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001080
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia